Free US stock screening tools combined with expert analysis to help you identify undervalued companies with strong growth potential. We use sophisticated algorithms and human expertise to surface opportunities that might otherwise go unnoticed.
Collegium Pharmaceutical Inc. (COLL) is trading at $34.59 as of 2026-04-20, posting a 0.52% gain on the day amid muted broad market action for mid-cap healthcare stocks. This analysis breaks down key technical levels, recent market context for the specialty pharmaceutical name, and potential scenarios for upcoming price action, with no investment recommendations included. Key observations include a tight recent consolidation range between well-defined support and resistance levels, neutral short
Collegium (COLL) Stock Bollinger Bands (Hovering) 2026-04-20 - IPO Watch
COLL - Stock Analysis
4278 Comments
1188 Likes
1
Shabrina
Active Reader
2 hours ago
Pure talent, no cap. π§’
π 127
Reply
2
Kazen
Legendary User
5 hours ago
This deserves endless applause. π
π 232
Reply
3
Lizette
Trusted Reader
1 day ago
Someone get a slow clap goingβ¦ π’π
π 125
Reply
4
Priyah
Consistent User
1 day ago
That deserves a slow-motion replay. π¬
π 288
Reply
5
Sadiah
New Visitor
2 days ago
US stock return on invested capital analysis and economic value added calculations to identify truly exceptional businesses with durable competitive advantages. Our quality metrics help you find companies that generate superior returns on capital employed in their business operations. We provide ROIC analysis, economic value added calculations, and capital efficiency metrics for comprehensive quality assessment. Find quality businesses with our comprehensive quality analysis and return metrics for long-term investment success.
π 160
Reply
Disclaimer: Not investment advice. For informational purposes only. Past performance does not guarantee future results. Trading involves substantial risk of loss.